Clinical Trials Logo

Hallucinations clinical trials

View clinical trials related to Hallucinations.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04661163 Active, not recruiting - Clinical trials for Auditory Hallucinations

CHALLENGE. A Randomised Clinical Trial Examining Virtual Reality Therapy

Start date: November 16, 2020
Phase: N/A
Study type: Interventional

The study is a randomised, assessor-blinded parallel-groups superiority clinical trial, allocating a total of 266 patients to either the experimental intervention or standard intervention. The participants will be randomised to either 12-weeks of virtual reality therapy or supportive counselling. All participants will be assessed at 12- and 24 weeks post baseline. A stratified block-randomisation with concealed randomisation sequence will be conducted. Independent assessors blinded to the treatment will evaluate outcome. Analysis of outcome will be carried out with the intention to treat principles.

NCT ID: NCT04167813 Active, not recruiting - Clinical trials for Dementia With Lewy Bodies

Trial of Ondansetron as a Parkinson's HAllucinations Treatment

TOP HAT
Start date: October 1, 2021
Phase: Phase 2
Study type: Interventional

TOPHAT (Trial of Ondansetron as a Parkinson's HAllucinations Treatment) is a double blind, individually randomized, placebo-controlled, parallel group, flexible dose trial of ondansetron (8-24mg/day) as a treatment for Parkinson's hallucinations, with a 12-week primary outcome and follow-up to 24 weeks.